Suchergebnisse - "Subklewe, Marion"

PubPharm (9)

1

Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia : a preclinical assessment

enthalten in: Leukemia | 2024

von Hänel, G. | Schönle, A. | Neumann, A. | +15

2

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)

enthalten in: Leukemia | 2024

von Ozga, M. | Nicolet, D. | Mrózek, K. | +37

3

A modular and controllable T cell therapy platform for acute myeloid leukemia

enthalten in: Leukemia | 2021

von Benmebarek, M. | Cadilha, B. | Herrmann, M. | +18

4

T-cell-based immunotherapy of acute myeloid leukemia : current concepts and future developments

enthalten in: Leukemia | 2021

von Daver, N. | Alotaibi, A. | Bücklein, V. | +1

5

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy : results from a multicenter, randomized, phase 2/3 study

enthalten in: Leukemia | 2021

von Montesinos, P. | Roboz, G. | Bulabois, C. | +22

6

Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

enthalten in: Leukemia | 2020

von Herold, T. | Rothenberg-Thurley, M. | Grunwald, V. | +19

7

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade

enthalten in: Leukemia | 2020

von Ruzicka, M. | Koenig, L. | Formisano, S. | +15

8

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study

enthalten in: Leukemia | 2018

von Braess, J. | Amler, S. | Kreuzer, K. | +43

9

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia

enthalten in: Leukemia | 2018

von Rothenberg-Thurley, M. | Amler, S. | Goerlich, D. | +15

1
[1]